Here are four quick notes:
1. The purchased 15,000 shares are worth $305,100.
2. K2M now accounts for about 0.31 percent of Deimos Asset Management’s portfolio.
3. On Jan. 3, 2017, K2M opened trading at $20.27 and ended at $20.34.
4. K2M has a market capitalization of $858 million.
More articles on devices:
House introduces bill to permanently repeal medical device tax: 4 things to know
Titan Medical names David McNally new CEO — 7 key points
NuVasive receives approval to continue XLIF procedures in Japan— 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
